Caffeine
Pronunciation: (KAF-een)Class: Analeptic
Trade Names:
Caffedrine
- Tablets 200 mg
Trade Names:
Maximum Strength NoDoz
- Tablets 200 mg
Trade Names:
Stay Awake
- Tablets 200 mg
Trade Names:
Vivarin
- Tablets 200 mg
Trade Names:
Keep Alert
- Tablets 200 mg
Trade Names:
357 HR Magnum
- Tablets 200 mg
Trade Names:
Overtime
- Tablets 200 mg
Trade Names:
20–20
- Tablets 200 mg
Trade Names:
Valentine
- Tablets 200 mg
Trade Names:
Keep Going
- Tablets 200 mg
Trade Names:
Molie
- Capsules 200 mg
Trade Names:
Fastlene
- Capsules 200 mg
Trade Names:
Enerjets
- Lozenges 75 mg
Trade Names:
Cafcit
- Oral solution 20 mg/mL (caffeine citrate; 2 mg caffeine citrate is equivalent to 1 mg caffeine base)
- Injection 20 mg/mL (caffeine citrate; 2 mg caffeine citrate is equivalent to 1 mg caffeine base)
Pharmacology
Increases calcium permeability in sarcoplasmic reticulum, inhibiting phosphodiesterase-promoting accumulation of cyclic AMP.
Pharmacokinetics
Absorption
99% absorbed orally. C max is 5 to 25 mcg/mL; T max is 15 to 120 min.
Distribution
Rapidly distributed throughout tissues; crosses the blood-brain barrier and placenta; excreted in breast milk. 17% to 36% protein bound. Vd is 0.64 kg.
Metabolism
Rapidly metabolized in the liver to 1-methyluric acid, 1-methylxanthine, and 7-methylxanthine; CYP1A2 is involved in the biotransformation.
Elimination
The t ½ is 3 to 5 h. Approximately 1% is excreted in the urine as unchanged drug.
Special Populations
Pregnancy, smoking, and cirrhosisThe t ½ is increased.
Indications and Usage
Fatigue and drowsiness; analgesia; apnea of prematurity; respiratory depression.
Contraindications
Caffeine and sodium benzoate solution in pediatrics.
Dosage and Administration
Fatigue/DrowsinessAdults and children (older than 12 yr of age)
PO 100 to 200 mg every 3 to 4 h as needed.
Apnea of PrematurityPreterm infants Loading dose (caffeine citrate)
IV 20 mg/kg (1 mL/kg) over 30 min once.
Maintenance dose (caffeine citrate)IV (over 10 min) or PO 5 mg/kg (0.25 mL/kg) every 24 h.
General Advice
- Do not administer tablets, capsules, or lozenges late in the day to avoid insomnia.
Storage/Stability
Store capsules, tablets, lozenges, and oral solution at controlled room temperature (59° to 86°F). Keep oral solution tightly capped. Citrated caffeine parenteral solution may be stored for up to 24 h at room temperature following dilution.
Drug Interactions
Aspirin, clozapine, theophyllinePlasma levels of these agents may be elevated by caffeine, increasing their pharmacologic effects and adverse reactions.
Cimetidine, disulfiram, fluoroquinolones, mexiletine, oral contraceptivesMay increase caffeine levels, enhancing the effects.
LithiumPlasma levels may be reduced by caffeine, decreasing the pharmacologic effect.
Phenytoin, smokingMay decrease caffeine levels.
Laboratory Test Interactions
False-positive elevations in serum urate measured by Bittner method; may increase urine levels of vanillymandelic acid, catecholamines, and 5-hydroxyindoleacetic acid, resulting in false-positive diagnosis of pheochromocytoma and neuroblastoma.
Adverse Reactions
Cardiovascular
Tachycardia; extrasystoles; palpitations; other cardiac arrhythmias.
CNS
Insomnia; restlessness; excitement; nervousness; tinnitus; scintillating scotoma; muscular tremor; headache; lightheadedness.
Dermatologic
Urticaria; rash, dry skin, skin breakdown (caffeine citrate).
EENT
Retinopathy of prematurity (caffeine citrate).
GI
Vomiting; nausea; diarrhea; stomach pain; necrotizing enterocolitis, gastritis, GI hemorrhage (caffeine citrate).
Genitourinary
Diuresis; kidney failure (caffeine citrate).
Hematologic
Disseminated intravascular coagulation (caffeine citrate).
Metabolic
Hyperglycemia; acidosis (caffeine citrate).
Respiratory
Dyspnea, lung edema (caffeine citrate).
Miscellaneous
Hypersensitivity (eg, dermatitis, rhinitis, bronchial asthma); feeding intolerance, sepsis, accidental injury, hemorrhage, cerebral hemorrhage (caffeine citrate).
Precautions
MonitorApneaMonitor neonates for apnea events and notify health care provider if noted. Caffeine intakeNote concurrent use of caffeine-containing beverages, foods, dietary supplements, or OTC products. Neonate caffeine serum levelsEnsure that caffeine serum levels have been determined in neonates who have been treated with theophylline before starting caffeine citrate therapy for apnea. |
Pregnancy
Category C .
Lactation
Excreted in breast milk.
Children
Caffeine and sodium benzoate injection is contraindicated in children.
Necrotizing enterocolitis
Other methylxanthines have been associated with development of necrotizing enterocolitis.
Depression
Too-vigorous treatment with parenteral caffeine can worsen depression.
GI effects
Caffeine may aggravate diarrhea in patients with irritable colon or exacerbate duodenal ulcers.
Seizure disorder
Seizures have been reported with caffeine overdose; use caffeine citrate with caution in infants with seizure disorders.
CV disease
Caffeine can increase heart rate, left ventricular output, and stroke volume; use caffeine citrate with caution in infants with CV disease.
Metabolic effects
Caffeine stimulates glycogenolysis and lipolysis, which increases free fatty acids and produces hyperglycemia.
Bone mineral density
Caffeine is associated with decreased bone density.
Withdrawal
Symptoms may occur within 12 h after cessation of chronic caffeine ingestion and persist up to 7 days.
Overdosage
Symptoms
Vomiting, myoclonus, agitation, myocardial irritability, cardiac arrhythmia, seizures, hematemesis, opisthotonus, decerebrate posturing, generalized muscular hypertonicity, rhabdomyolysis with renal failure, pulmonary edema, hyperglycemia; hypokalemia, leukocytosis, ketosis, metabolic acidosis, death.
Patient Information
- Caution patient to not exceed recommended dose.
- Inform patient that caffeine is not a substitute for normal sleep.
- Advise pregnant women to limit intake of caffeine and caffeine-containing beverages to a minimum.
- Warn patient that withdrawal symptoms may occur within 12 to 24 h following cessation of chronic caffeine ingestion. Symptoms consist of headache, fatigue, depression, anxiety or insomnia and may last for up to 7 days.
- Advise patient to discontinue use if increased or abnormal heart rate, palpitations, dizziness, agitation, nervousness, or insomnia occur.
- Caffeine citrate
- Instruct parents or caregiver in proper measurement of dose.
- Caution parents or caregiver that if baby continues to have apnea events to contact the baby's health care provider and to not increase the dose of caffeine citrate unless advised to do so by health care provider.
- Advise parents or caregivers to contact the baby's health care provider if the baby seems lethargic or develops abdominal distention, vomiting, or bloody stools.
| Link to Page | Print Page | Email Page | Add to List |
More Caffeine resources
Caffeine - Includes detailed dosage instructions.
Compare Caffeine with other medications for the treatment of:
Apnea of Prematurity, Drowsiness
